Search

Your search keyword '"Alegre-Sancho, J. J."' showing total 78 results

Search Constraints

Start Over You searched for: Author "Alegre-Sancho, J. J." Remove constraint Author: "Alegre-Sancho, J. J."
78 results on '"Alegre-Sancho, J. J."'

Search Results

1. POS0851 USE OF NAILFOLD CAPILLAROSCOPY AS A PREDICTOR OF CARDIOVASCULAR EVENTS AND MORTALITY IN SYSTEMIC SCLEROSIS

2. POS0832 IMMUNOSUPPRESSION VERSUS COMBINATION OF IMMUNOSUPPRESSION AND ORAL GLUCOCORTICOIDS FOR SKIN FIBROSIS IN EARLY DIFFUSE SYSTEMIC SCLEROSIS PATIENTS. A TARGET TRIAL EMULATION STUDY FROM THE EUSTAR DATABASE

3. AB1233 ROLE OF HEMATOLOGICAL INDICES IN SYSTEMIC SCLEROSIS: USE AS A PREDICTOR OF SUBCLINICAL VASCULAR DAMAGE, CARDIOVASCULAR EVENTS AND DEATH

4. AB1000 ANIFROLUMAB IN SYSTEMIC LUPUS ERYTHEMATOSUS. SPANISH NATIONAL REGISTRY IN A REAL-WORLD SETTING

5. AB1354 SPANISH NATIONAL MULTICENTER REGISTRY OF PREGNANCY IN SYSTEMIC AUTOINMUNE RHEUMATIC DISEASES

9. Replication of PTPRC as genetic biomarker of response to TNF inhibitors in patients with rheumatoid arthritis

10. POS0914 LATE SKIN FIBROSIS IN SYSTEMIC SCLEROSIS: A STUDY FROM THE EUSTAR COHORT

13. EFFECTIVENESS AND SAFETY OF TOCILIZUMAB IN PATIENTS WITH SYSTEMIC SCLEROSIS: A PROPENSITY SCORE CONTROL MATCHED OBSERVATIONAL STUDY OF THE EUSTAR COHORT

15. POS0861 EFFECTIVENESS AND SAFETY OF TOCILIZUMAB IN PATIENTS WITH SYSTEMIC SCLEROSIS: A PROPENSITY SCORE CONTROL MATCHED OBSERVATIONAL STUDY OF THE EUSTAR COHORT

17. FRI0446 VIRAL ARTHRITIS: DESCRIPTIVE ANALYSIS OF A SERIES OF 131 PATIENTS

20. AB0806 DOES VITAMIN D INFLUENCE THE ACTIVITY OF THE DISEASE IN PATIENTS WITH PSORIATIC ARTHRITIS?

21. AB0711 USEFULNESS OF THE TRABECULAR BONE SCORE AS A PREDICTOR OF VERTEBRAL FRACTURE IN PATIENTS WITH AXIAL SPONDYLOARTHROPATHY

22. AB0595 EFFECTIVENESS OF TOPICAL SODIUM TIOSULFATE FOR THE TREATMENT OF CALCINOSIS-ASSOCIATED CUTANEOUS ULCERS IN PATIENTS WITH SYSTEMIC SCLEROSIS

23. THU0307 RESPONSE OF BEHÇET’S REFRACTORY ORAL AND/OR GENITAL ULCERS TO APREMILAST IN COMBINATION VS MONOTHERAPY. NATIONAL MULTICENTER STUDY OF 51 CASES OF CLINICAL PRACTICE

24. AB0620 EFFECTIVENESS OF RITUXIMAB IN PATIENTS WITH EARLY DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS. A MULTICENTER ANALYSIS.

25. AB0807 VITAMIN D ROLE IN VASCULAR DAMAGE PROGRESSION IN PATIENTS WITH PSORIATIC ARTHRITIS

26. AB0163 ANTI-KU ANTIBODIES: MUCH MORE THAN SCLEROMYOSITIS

27. FRI0377 BARIATRIC SURGERY: EFFECTS ON BONE METABOLISM

28. Update of EULAR recommendations for the treatment of systemic sclerosis

29. GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways

32. RITUXIMAB IN SYSTEMIC SCLEROSIS : SAFETY AND EFFICACY DATA FROM THE EUSTAR NETWORK

33. Incidence and predictors of cutaneous manifestations during the early course of systemic sclerosis. a 10-year longitudinal study from the EUSTAR database

36. Replication of PTPRC as genetic biomarker of response to TNF inhibitors in patients with rheumatoid arthritis

37. AB0221 Correlation between rheumatoid arthritis and periodontal disease

38. FRI0378 Interleukin 6 and vascular disease in patients with systemic sclerosis

39. Bosentan therapy for cutaneous fibrosis in systemic sclerosis

44. Is there a role for TNF-alpha antagonists in the treatment of SSc? EUSTAR expert consensus development using the Delphi technique

45. Confirmation of CCR6 as a risk factor for anti-topoisomerase I antibodies in systemic sclerosis

46. Fibromyalgia prevalence and related factors in a large registry of patients with systemic lupus erythematosus

47. LILRA3 deficiency is not involved in the giant cell arteritis and systemic sclerosis predisposition

Catalog

Books, media, physical & digital resources